Inotuzumab ozogamicin for treating pediatric R/R ALL

Blinatumomab and inotuzumab in children with R/R B-ALLПодробнее

Improving adult ALL treatment: pediatric regimens & adding inotuzumabПодробнее

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of ...Подробнее

Alliance A041501: the addition of inotuzumab to a pediatric-inspired chemo regimen for B-ALLПодробнее

Inotuzumab ozogamicin in the treatment of patients with R/R ALL and extramedullary diseaseПодробнее

Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemiasПодробнее

Choosing between inotuzumab ozogamicin and blinatumomab in patients with R/R ALLПодробнее

The evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with ALLПодробнее

Phase II trial of inotuzumab ozogamicin to treat MRD+ B-ALLПодробнее

Treatment Advances for Acute Lymphoblastic Leukemia (ALL) In Children and AdultsПодробнее

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in R/R ALLПодробнее

Phase II study of inotuzumab ozogamicin in MRD+ B-ALLПодробнее

A Phase II study of ruxolitinib with chemotherapy in pediatric patients with Ph-like ALLПодробнее

Inotuzumab ozogamicin for MRD-positive B-ALLПодробнее

Pediatric Rheumatology at Children's of AlabamaПодробнее

Dr. Brammer on Data With Inotuzumab Ozogamicin in ALLПодробнее

What is the role of inotuzumab ozogamicin in ALLПодробнее

Management Perspective of Pediatric ALL and AML_Dr Amita MahajanПодробнее

Treating pediatric patients with hematological malignanciesПодробнее